Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolic Syndrome and Prostate Cancer: a Review of Complex Interplay Amongst Various Endocrine Factors in the Pathophysiology and Progression of Prostate Cancer.

Hormones & cancer - 1 Apr 2016

Rhee Handoo, Vela Ian, Chung Eric

Abstract excerpt

The human prostate gland is an endocrine organ where dysregulation of various hormonal factors may play a pivotal role in the pathogenesis of prostate cancer. There is emerging epidemiological data to support the role of components of metabolic syndrome, namely, obesity, hypercholesterolaemia, diabetes and hyperinsulinaemia on the development and/or the progression of prostate cancer. Although the exact...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adiponectin
Share to Disease Progression
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leptin

Share to Metabolic Syndrome

Share to Prostatic Neoplasms

Share to Testosterone

Source

Open in PubMed Open full text

Identifiers

PMID: 26546071
DOI: 10.1007/s12672-015-0238-x
PMCID: PMC10355963

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabolic Syndrome and Prostate Cancer: a Review of Complex Interplay Amongst Various Endocrine Factors in the Pathophysiology and Progression of Prostate Cancer.PMID 26546071Read ↗

Leptin signalling, obesity and prostate cancer: molecular and clinical perspective on the old dilemma.Semantic proximity Read ↗

Alteration of Lipid Metabolism in Prostate Cancer: Multifaceted Oncologic ImplicationsSemantic proximity Read ↗

Leptin and prostate: implications for cancer prevention--overview of genetics and molecular interactions.Semantic proximity Read ↗

Decoding the Influence of Obesity on Prostate Cancer and Its Transgenerational ImpactSemantic proximity Read ↗

New insights into lipid metabolism and prostate cancer (Review)Semantic proximity Read ↗

The relationship between metabolic syndrome components and prostate cancer risk : a Mendelian randomization studySemantic proximity Read ↗

Prostate cancer: from the pathophysiologic implications of some genetic risk factors to translation in personalized cancer treatments.Semantic proximity Read ↗

[Molecular and endocrinological mechanism of benign prostatic hyperplasia and prostate cancer].Semantic proximity Read ↗

Natural Products in Prostate Cancer: Crosstalk among the Gut Microbiome, Androgen Receptor Signaling, and Epigenetic RegulationSemantic proximity Read ↗

The single nucleotide polymorphism rs700518 is an independent risk factor for metabolic syndrome and benign prostatic hyperplasia (MetS-BPH).Semantic proximity Read ↗

Endocrine Disruptors and Prostate CancerSemantic proximity Read ↗

Personalized Medicine for Prostate Cancer: Is Targeting Metabolism a Reality?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.